Immunosuppression in cancer therapeutics.
D000818:Animals; D003561:Cytarabine / Q000627:therapeutic use; D006084:Graft Rejection; D006801:Humans; D006835:Hydrazones / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007942:Leukemia, Experimental / Q000188:drug therapy; D051379:Mice; D008808:Mice, Inbred CBA; D008811:Mice, Inbred DBA; D016038:Skin Transplantation; D014184:Transplantation, Homologous
D006835:Hydrazones; D007166:Immunosuppressive Agents; D003561:Cytarabine